Intriguingly, NF-κB inhibition in astrocytes did not confer protective benefits and, in some cases, appeared detrimental [51], suggesting that microglia and astrocytes may influence ALS progression through distinct mechanisms. This evidence concerns the gene NFKB1 and amyotrophic lateral sclerosis.